Fulgent Genetics (FLGT) Change in Cash (2015 - 2026)

Fulgent Genetics has reported Change in Cash for 12 years, with the latest figure at $2.9 million in Q2 2026.

• Quarterly Change in Cash fell 85.89% year-over-year to $2.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$61.6 million (down 368.84% YoY) and the FY2025 annual result came in at -$5.0 million, up 88.27% from the prior year.
• Change in Cash advanced to $2.9 million in Q2 2026 per FLGT's latest filing, from -$26.8 million in the prior quarter.
• Over five years, Change in Cash peaked at $188.2 million in Q1 2022 and troughed at -$214.3 million in Q2 2022.
• A 5-year average of -$7.7 million and a median of $4000.0 in 2024 frame the typical range for Change in Cash.
• The widest YoY moves for Change in Cash: up 529.2% in 2025, down 2227.4% in 2025.
• Over 5 years, Change in Cash stood at -$89.3 million in 2022, then surged by 115.01% to $13.4 million in 2023, then tumbled by 121.63% to -$2.9 million in 2024, then sank by 2227.4% to -$67.4 million in 2025, then jumped by 104.31% to $2.9 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered $2.9 million, -$26.8 million, and -$67.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.